Summary of results B.
Placebo comparators | Studies | Attacks treated | Treatment (%) | Comparator (%) | Relative risk (95% CI) | NNTp (95% CI) |
---|---|---|---|---|---|---|
Aspirin (m± metoclopramide) versus placebo | 8 | 2922 | 44 | 65 | 0.68 (0.63 to 0.73) 4 | 8 (4.1 to 5.7) |
Aspirin 1000 mg versus placebo | 5 | 1881 | 42 | 63 | 0.67 (0.61 to 0.73) | 4.8 (3.9 to 6.0) |
Aspirin 900 mg plus metoclopramide 10 mg versus placebo | 3 | 1041 | 48 | 69 | 0.69 (0.62 to 0.77) | 4.7 (3.7 to 6.5) |
Active comparators | Studies | Attacks treated | Treatment (%) | Comparator (%) | Relative risk (95% CI) | NNH (95% CI) |
Aspirin (± metoclopramide) versus sumatriptan 50 mg or 100 mg | 4 | 1340 | 49 | 43 | 1.1 (1.01 to 1.3) | 17 (8.8 to 140) |
Aspirin 1000 mg versus sumatriptan 50 mg | 2 | 726 | 44 | 40 | 1.1 (0.92 to 1.3) | Not calculated |
Aspirin 900 mg plus metoclopramide 10 mg versus sumatriptan 100 mg | 2 | 614 | 55 | 46 | 1.2 (1.01 to 1.4) | 11 (6.0 to 120) |